Fig. 2From: Benefits and harms of implementing [18F]FDG-PET/CT for diagnosing recurrent breast cancer: a prospective clinical studyPrior and posterior probabilities for metastatic breast cancer, any metastatic cancer, and incidental malignancies according to [18F]FDG-PET/CTBack to article page